PlainRecalls
FDA Drug Low Class III Terminated

NABUMETONE Tablets USP, 750 mg, 100 count bottle,Teva Pharmaceutical Industries Ltd., Jerusalem, 91010, ISRAEL

Reported: March 23, 2016 Initiated: November 19, 2015 #D-0773-2016

Product Description

NABUMETONE Tablets USP, 750 mg, 100 count bottle,Teva Pharmaceutical Industries Ltd., Jerusalem, 91010, ISRAEL

Reason for Recall

Labeling: Not Elsewhere Classified: Lack of leaflets and approved labels on bottles.

Details

Recalling Firm
Teva Pharmaceuticals USA
Units Affected
576 bottles
Distribution
Nationwide and Puerto Rico.
Location
North Wales, PA

Frequently Asked Questions

What product was recalled?
NABUMETONE Tablets USP, 750 mg, 100 count bottle,Teva Pharmaceutical Industries Ltd., Jerusalem, 91010, ISRAEL. Recalled by Teva Pharmaceuticals USA. Units affected: 576 bottles.
Why was this product recalled?
Labeling: Not Elsewhere Classified: Lack of leaflets and approved labels on bottles.
Which agency issued this recall?
This recall was issued by the FDA Drug on March 23, 2016. Severity: Low. Recall number: D-0773-2016.